Current role
Drug Manufacturers - Specialty & Generic · Healthcare
COO
Kevin McCulloch
Equibles does not estimate personal net worth.
Get an email with a short summary when Xeris Biopharma Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get XERS alertsAbout Kevin McCulloch
Kevin McCulloch is recorded as COO at Xeris Biopharma Holdings, Inc. (XERS). The newest filing on record that lists Kevin McCulloch as COO at Xeris Biopharma Holdings, Inc. (XERS) is dated April 23, 2026. Xeris Biopharma Holdings, Inc. reported in an 8-K filed August 2, 2024 that Kevin McCulloch was appointed President and Chief Operating Officer, effective August 1, 2024. The proxy statement of Xeris Biopharma Holdings, Inc. reports total compensation of $2,270,973 for Kevin McCulloch in fiscal 2025, including a base salary of $543,833. Disclosed compensation is on record for 2 fiscal years. Xeris Biopharma Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Xeris Biopharma Holdings, Inc. includes John P. Shannon (CEO and Board Member), John Shannon (CEO, Chairman, COO and Board Member), Marla S. Persky (Chairman) and 7 others.
“The Board of Directors of Xeris Biopharma Holdings, Inc. (the “Company”) promoted Kevin McCulloch to be President and Chief Operating Officer of the Company, effective as of August 1, 2024.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Xeris Biopharma Holdings, Inc.
- John P. Shannon CEO, Board Member
- John Shannon CEO, Chairman, COO, Board Member
- Marla S. Persky Chairman
- Steven M. Pieper CFO
- Beth P. Hecht General Counsel
- Dawn Halkuff Board Member
- Jeffrey W. Sherman Board Member
- John H. Johnson Board Member
- John Johnson Board Member
- Menassie Taddese Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $543,833 | $2,270,973 |
| 2024 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $490,349 | $2,577,572 |